KEYNOTE-585
Phase 3 Completed
1,007 enrolled 25 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
Phase 2 Completed
6 enrolled
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
Phase 1/2 Completed
71 enrolled
FLOT5
Phase 3 Completed
183 enrolled
Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC
Phase 2 Completed
24 enrolled
Docetaxel and Irinotecan in Gastric Cancer
Phase 2 Completed
32 enrolled
CHANGE
Phase 2/3 Completed
270 enrolled
PRODIGY
Phase 3 Completed
530 enrolled 11 charts
Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage â…¢ Clinical Study
Phase 2 Completed
300 enrolled
IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma
Phase 1 Completed
33 enrolled
MATCH
Phase 2 Completed
180 enrolled
RAMSES/FLOT7
Phase 2/3 Completed
180 enrolled
MATEO
Phase 2 Completed
242 enrolled
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Phase 2 Completed
68 enrolled
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
Phase 2 Completed
40 enrolled
Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
Phase 1 Completed
22 enrolled 6 charts
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Phase 2 Completed
111 enrolled 11 charts
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Phase 2 Completed
213 enrolled 17 charts
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
Phase 2 Completed
18 enrolled 10 charts
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Phase 2/3 Completed
716 enrolled
Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
Phase 2 Completed
39 enrolled 10 charts
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
Phase 2 Completed
27 enrolled 10 charts
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
Phase 1/2 Completed
59 enrolled 16 charts
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Phase 2 Completed
180 enrolled
Avastin and Taxotere for Esophagogastric Cancer
Phase 2 Completed
42 enrolled
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
73 enrolled 13 charts
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2 Completed
40 enrolled 10 charts
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Phase 2 Completed
38 enrolled 10 charts
Dovitinib Plus Docetaxel in Gastric Cancer
Phase 1/2 Completed
14 enrolled
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
Phase 2 Completed
46 enrolled
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
Phase 2 Completed
67 enrolled
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
Phase 1/2 Completed
98 enrolled 8 charts
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
Phase 2 Completed
158 enrolled 13 charts
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
Phase 2 Completed
47 enrolled
A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer
Phase 1 Completed
25 enrolled
FLOT3
Phase 2 Completed
252 enrolled
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Phase 2 Completed
48 enrolled 8 charts
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Phase 2 Completed
22 enrolled 6 charts
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
33 enrolled
Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer
Phase 2 Completed
40 enrolled
Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction
Phase 1/2 Completed
25 enrolled
DaeMon
Phase 2 Completed
39 enrolled
NEOTAX
Phase 2 Completed
59 enrolled
Docetaxel and Epirubicin in Advanced Gastric Cancer
Phase 2 Completed
34 enrolled 5 charts
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
Phase 3 Completed
320 enrolled
P-HDFL-DI
Phase 2 Completed
29 enrolled
Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
Phase 2 Completed
56 enrolled
DoCCS
Phase 2 Completed
50 enrolled